AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC
Go back to AMGEN TO PRESENT NEW REPATHA® (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.38 -0.96 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $440.34 | 52 Week High | $176.85 | |||
| Open | $433.08 | 52 Week Low | $133.64 | |||
| Day High | $439.40 | P/E | 66.17 | |||
| Day Low | $431.01 | EPS | $6.64 | |||
| Volume | 420,947 | |||||

